TY  - JOUR
T1  - HEalth care fraud
AU  - Mitka M
Y1  - 2012/02/08
N1  - 10.1001/jama.2012.90
JO  - JAMA
SP  - 553
EP  - 553
VL  - 307
IS  - 6
N2  - 
Enforcement actions involving the pharmaceutical industry were the source of the largest recoveries in 2011, totaling almost $2.2 billion. One of the largest recoveries reported by the Justice Department was $900 million from 8 drug makers to resolve allegations that they had engaged in unlawful pricing to increase profits. Another was $750 million paid by GlaxoSmithKline to resolve criminal and civil allegations that the company knowingly submitted, or caused to be submitted, false claims to government health programs for adulterated drugs and for drugs that failed to conform with the strength, purity, or quality specified by the Food and Drug Administration.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.90
UR  - http://dx.doi.org/10.1001/jama.2012.90
ER  -